Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: Patient characteristics at time of LVAD implantation.

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques: Functional Assay

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: Cause of death 30 days after LVAD (total n = 14).

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques:

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: Retention parameters at LVAD implantation and after 30 days. ( A ) Creatinine. ( B ) BUN. ( C ) eGFR *** P < 0.01. MDRD (Modification of Diet in Renal Disease).

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques: Modification

Journal: Scientific Reports

Article Title: Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation

doi: 10.1038/s41598-018-26515-0

Figure Lengend Snippet: ( A ) Kaplan Meier survival curve 30 days after LVAD implantation. Log rank P = 0.004. ( B ) Kaplan Meier survival curve 30 days after LVAD implantation. Log rank P = 0.003.

Article Snippet: All patients received a continuous-flow 3 rd generation LVAD (HVAD Heartware Inc., Framingham, USA) for a severe HF at our institution.

Techniques:

Journal: Intensive Care Medicine

Article Title: Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)

doi: 10.1007/s00134-020-05939-1

Figure Lengend Snippet: Baseline and peri-operative characteristics of patients undergoing continuous-flow LVAD implantation

Article Snippet: Between January 1, 2006, and May 31, 2017, a total of 2988 adult patients who underwent continuous-flow LVAD implantation with mainstream devices (HeartWare, HeartMate II, or HeartMate 3) were included.

Techniques: Functional Assay

Journal: Intensive Care Medicine

Article Title: Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)

doi: 10.1007/s00134-020-05939-1

Figure Lengend Snippet: Detailed time-based presentation of causes of death within 90 days following LVAD implantation in the EUROMACS registry. For abbreviations, see Fig.

Article Snippet: Between January 1, 2006, and May 31, 2017, a total of 2988 adult patients who underwent continuous-flow LVAD implantation with mainstream devices (HeartWare, HeartMate II, or HeartMate 3) were included.

Techniques:

Journal: Intensive Care Medicine

Article Title: Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)

doi: 10.1007/s00134-020-05939-1

Figure Lengend Snippet: Flowchart of the study population. This flowchart describes the outcome in total population of EUROMACS over follow-up of 90 days. EUROMACS The European Registry for Patients with Mechanical Circulatory Support, LVAD left ventricular assist device

Article Snippet: Between January 1, 2006, and May 31, 2017, a total of 2988 adult patients who underwent continuous-flow LVAD implantation with mainstream devices (HeartWare, HeartMate II, or HeartMate 3) were included.

Techniques:

Journal: Intensive Care Medicine

Article Title: Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)

doi: 10.1007/s00134-020-05939-1

Figure Lengend Snippet: Baseline univariate predictors of early mortality after LVAD implantation using continuous values

Article Snippet: Between January 1, 2006, and May 31, 2017, a total of 2988 adult patients who underwent continuous-flow LVAD implantation with mainstream devices (HeartWare, HeartMate II, or HeartMate 3) were included.

Techniques:

Journal: Intensive Care Medicine

Article Title: Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)

doi: 10.1007/s00134-020-05939-1

Figure Lengend Snippet: Comparison of goodness of fit between the multivariable models using continuous versus categorical values. Receiver-operating characteristic curves showing similar area under the curve of the two models in predicting early (< 90 day) death following LVAD implantation

Article Snippet: Between January 1, 2006, and May 31, 2017, a total of 2988 adult patients who underwent continuous-flow LVAD implantation with mainstream devices (HeartWare, HeartMate II, or HeartMate 3) were included.

Techniques: Comparison

Journal: Journal of cardiac surgery

Article Title: Fate of preoperative moderate mitral regurgitation following left ventricular assist device implantation

doi: 10.1111/jocs.15428

Figure Lengend Snippet: Pre-cfLVAD echocardiographic findings

Article Snippet: AI aortic insufficiency cfLVAD continuous-flow left ventricular assist device HM HeartMate HVAD HeartWare LVAD ICU intensive care unit LA left atrium LV left ventricle LVAD left ventricular assist device LVEDD left ventricular end diastolic diameter LVESD left ventricular end systolic diameter MCS mechanical circulatory support PCWP pulmonary capillary wedge pressure MR mitral regurgitation MV mitral valve RV right ventricle RVD right ventricular dysfunction RVF right ventricular failure RVSWI right ventricular stroke work index SVO 2 mixed venous oxygen saturation TCS temporary circulatory support TR tricuspid regurgitation

Techniques:

Journal: Journal of cardiac surgery

Article Title: Fate of preoperative moderate mitral regurgitation following left ventricular assist device implantation

doi: 10.1111/jocs.15428

Figure Lengend Snippet: Post-cfLVAD echocardiographic findings

Article Snippet: AI aortic insufficiency cfLVAD continuous-flow left ventricular assist device HM HeartMate HVAD HeartWare LVAD ICU intensive care unit LA left atrium LV left ventricle LVAD left ventricular assist device LVEDD left ventricular end diastolic diameter LVESD left ventricular end systolic diameter MCS mechanical circulatory support PCWP pulmonary capillary wedge pressure MR mitral regurgitation MV mitral valve RV right ventricle RVD right ventricular dysfunction RVF right ventricular failure RVSWI right ventricular stroke work index SVO 2 mixed venous oxygen saturation TCS temporary circulatory support TR tricuspid regurgitation

Techniques: